StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Trifluoroacetic acid → 3-(3-(cyclopropanecarboxamido)-1H-indazol-6-ylamino)-4-methyl-N-(3-(trifluoro-methyl)phenyl)benzamide

HRID 876896
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 876896
[CH:1]1([C:4]([NH:6][C:7]2[C:15]3[C:10](=[CH:11][C:12]([NH:16][C:17]4[CH:18]=[C:19]([CH:33]=[CH:34][C:35]=4[CH3:36])[C:20]([NH:22][C:23]4[CH:28]=[CH:27][CH:26]=[C:25]([C:29]([F:32])([F:31])[F:30])[CH:24]=4)=[O:21])=[CH:13][CH:14]=3)[N:9](COCC[Si](C)(C)C)[N:8]=2)=[O:5])[CH2:3][CH2:2]1.[C:45]([OH:51])([C:47]([F:50])([F:49])[F:48])=[O:46]>C(Cl)Cl>[C:45]([OH:51])([C:47]([F:50])([F:49])[F:48])=[O:46].[CH:1]1([C:4]([NH:6][C:7]2[C:15]3[C:10](=[CH:11][C:12]([NH:16][C:17]4[CH:18]=[C:19]([CH:33]=[CH:34][C:35]=4[CH3:36])[C:20]([NH:22][C:23]4[CH:28]=[CH:27][CH:26]=[C:25]([C:29]([F:31])([F:30])[F:32])[CH:24]=4)=[O:21])=[CH:13][CH:14]=3)[NH:9][N:8]=2)=[O:5])[CH2:3][CH2:2]1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

5

Edukt 2

HCID 6422Trifluoroacetic acidHCID 674006613-(3-(cyclopropanecarboxamido)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazol-6-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide

Produkt 2

HCID 6422Trifluoroacetic acidHCID 682341303-(3-(cyclopropanecarboxamido)-1H-indazol-6-ylamino)-4-methyl-N-(3-(trifluoro-methyl)phenyl)benzamideAusbeute 66 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

To a solution of 3-(3-(cyclopropanecarboxamido)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazol-6-ylamino)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide (25 mg) in CH2Cl2 (1 mL) was added TFA (0.25 mL) at room temperature. The reaction mixture was stirred for 2 hours and the organic solvent was concentrated under reduced pressure. To a solution of the resulting mixture in THF (0.5 mL) and MeOH (0.5 mL) was added LiOH aqueous solution (1.0 M, 1.0 mL). The resulting mixture was stirred for another 2 hours at room temperature. The organic solvent was removed under reduced pressure and the aqueous layer was extracted with ethyl acetate. The organic extracts were washed with brine, dried over MgSO4 and concentrated under reduced pressure. The crude product was purified by Prep HPLC and acetonitrile was removed under reduced pressure. The remained water was freeze-dried to afford TFA salt of title compound (16 mg, 66%), MS (ESI) m/z 494 (M+H)+.

Aufarbeitung

  1. concentrationthe organic solvent was concentrated under reduced pressure
  2. additionTo a solution of the resulting mixture in THF (0.5 mL) and MeOH (0.5 mL) was added LiOH aqueous solution (1.0 M, 1.0 mL)
  3. stirringThe resulting mixture was stirred for another 2 hours at room temperature
  4. customThe organic solvent was removed under reduced pressure
  5. extractionthe aqueous layer was extracted with ethyl acetate
  6. washThe organic extracts were washed with brine
  7. dry with materialdried over MgSO4
  8. concentrationconcentrated under reduced pressure
  9. customThe crude product was purified by Prep HPLC and acetonitrile
  10. customwas removed under reduced pressure
  11. dry with materialThe remained water was freeze-dried

Quellen und Nachweise

ORD-Eintrag
ord-9baaf77a3f124a35afddd07456819914
Quelldatensatz
uspto-grants-2015_03
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08987275B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion